BRIEF-Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates

reuters11-06

Nov 6 (Reuters) - Sonnet Biotherapeutics Holdings Inc SONN.O:

SONNET BIOTHERAPEUTICS ANNOUNCES ISSUANCE OF U.S. PATENT COVERING A VARIANT IL-18 INCORPORATED INTO TWO NOVEL IMMUNOTHERAPEUTIC DRUG CANDIDATES
SONNET BIOTHERAPEUTICS HOLDINGS INC - PATENT TERM EFFECTIVE UNTIL JUNE 2044

Source text: ID:nGNX6jmHxy

Further company coverage: SONN.O

(Reuters.Briefs@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481601442?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-06 21:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2481601442","market":"us","top_or_hot":-1,"title":"BRIEF-Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates","media":"reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates</title></head><body><p><span>Nov 6 (Reuters)</span><span> - </span>Sonnet Biotherapeutics Holdings Inc <span>SONN.O</span>:</p><ul><li><p>SONNET BIOTHERAPEUTICS ANNOUNCES ISSUANCE OF U.S. PATENT COVERING A VARIANT IL-18 INCORPORATED INTO TWO NOVEL IMMUNOTHERAPEUTIC DRUG CANDIDATES</p></li><li><p>SONNET BIOTHERAPEUTICS HOLDINGS INC - PATENT TERM EFFECTIVE UNTIL JUNE 2044</p></li></ul><p>Source text: <span>ID:nGNX6jmHxy</span></p><p>Further company coverage: <span>SONN.O</span></p><p> (Reuters.Briefs@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-06 21:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nTUA1XSL2D:1><strong>reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug CandidatesNov 6 (Reuters) - Sonnet Biotherapeutics Holdings Inc...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nTUA1XSL2D:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nTUA1XSL2D:1","article_id":"2481601442","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481601442","pubTimestamp":1730900274,"sourceInfo":null,"weMediaInfo":{"media_name":"reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug CandidatesNov 6 (Reuters) - Sonnet Biotherapeutics Holdings Inc","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","SONN":"Sonnet BioTherapeutics Holdings, Inc."},"translate_title":"简介-Sonnet Biotherapeutics宣布授予美国专利，涵盖纳入两种新型免疫治疗候选药物的变体IL-18","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SONN":0.9},"content_text":"BRIEF-Sonnet Biotherapeutics Announces Issuance Of US Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug CandidatesNov 6 (Reuters) - Sonnet Biotherapeutics Holdings Inc SONN.O:SONNET BIOTHERAPEUTICS ANNOUNCES ISSUANCE OF U.S. PATENT COVERING A VARIANT IL-18 INCORPORATED INTO TWO NOVEL IMMUNOTHERAPEUTIC DRUG CANDIDATESSONNET BIOTHERAPEUTICS HOLDINGS INC - PATENT TERM EFFECTIVE UNTIL JUNE 2044Source text: ID:nGNX6jmHxyFurther company coverage: SONN.O (Reuters.Briefs@thomsonreuters.com)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481601442"}